Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...
The United Kingdom is trying to kill two birds with one stone. British Health Secretary Wes Streeting has blamed ‘widening waistbands’ for adding to the pressure on the National Health Service (NHS).